According to the latest report by IMARC Group, titled “Inhaled Nitric Oxide Market: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”, the global inhaled nitric oxide market exhibited moderate growth during 2015-2020 and expects the market to grow at a CAGR of around 6% during 2021-2026.
Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator that skilled doctors supervise at tertiary neonatal intensive care units (NICUs). It aids in regulating vascular muscle tone and treating hypoxemic respiratory failure among newborn children by enhancing ventilation-perfusion mismatch and minimizing hypertension and elevated pulmonary vascular resistance. Inhaled nitric oxide also assists in decreasing the need for extracorporeal membrane oxygenation (ECMO) and improving oxygenation. Currently, iNO therapy is being increasingly used as a rescue agent for acute respiratory distress syndrome (ARDS) patients.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Inhaled Nitric Oxide Market Trends:
The rising prevalence of various respiratory and other subsequent diseases in newborns, including persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), is driving the inhaled nitric oxide market. Furthermore, the growing geriatric population, who are more prone to atherosclerosis, hypertension, peripheral artery disease, thrombosis, etc., is also augmenting the product demand. Moreover, iNO is gaining immense traction for the treatment of chronic obstructive pulmonary disease (COPD), ARDS, asthma, etc. Additionally, iNO therapy is also being used against coronavirus stains as it helps in improving ventilation/perfusion in patients with severe pneumonia. Besides this, the ongoing research and development (R&D) activities in the healthcare industry are anticipated to bolster the market growth in the coming years.
Request Free Sample Report: https://www.imarcgroup.com/inhaled-nitric-oxide-market/requestsample
Global Inhaled Nitric Oxide Market 2021-2026 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.
The report has segmented the market on the basis on region and application.
Breakup by Application:
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
Breakup by Region:
- North America:( United States, Canada)
- Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico,Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/inhaled-nitric-oxide-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Company Name: IMARC Group
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal